COVID-19 Seroprevalence in Pregnant Women and Blood Donors
NCT ID: NCT04893057
Last Updated: 2024-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
797 participants
OBSERVATIONAL
2022-09-15
2023-01-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy
NCT04402918
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
NCT04388605
COVID-19 Seroprevalence Study in French Guiana
NCT04490850
Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP
NCT04442087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women
Women admitted to hospital for a live birth.
No interventions assigned to this group
Blood donors
Subjects qualified for whole blood donation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult female
* Admitted to hospital for live birth
* Informed consent
* Affiliated to the French social security health insurance scheme
* Blood donors
* Adult male or female
* Qualified for whole blood donation (up to 70 years old in France)
* Informed consent
* Affiliated to the French social security health insurance scheme
Exclusion Criteria
* Subject without health insurance coverage
* Exclusion period of another study or exclusion period of the French national healthy volunteer registry
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxime Desmarets, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU Besançon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de besançon
Besançon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.